VIST vs. AXSM
VIST (Vista Oil & Gas, S.A.B. de C.V.) and AXSM (Axsome Therapeutics, Inc.) are both stocks. VIST operates in Oil & Gas E&P (Energy), while AXSM operates in Biotechnology (Healthcare). Over the past 5 years, VIST returned 80.45%/yr vs 30.90%/yr for AXSM. At a 0.14 correlation, their price movements are largely independent.
Performance
VIST vs. AXSM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VIST achieves a 48.25% return, which is significantly higher than AXSM's 39.71% return.
VIST
- 1D
- -1.21%
- 1M
- -0.21%
- YTD
- 48.25%
- 6M
- 45.86%
- 1Y
- 35.98%
- 3Y*
- 48.18%
- 5Y*
- 80.45%
- 10Y*
- —
AXSM
- 1D
- 0.55%
- 1M
- 12.05%
- YTD
- 39.71%
- 6M
- 72.21%
- 1Y
- 145.12%
- 3Y*
- 50.48%
- 5Y*
- 30.90%
- 10Y*
- 44.70%
VIST vs. AXSM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
VIST Vista Oil & Gas, S.A.B. de C.V. | 48.25% | -10.07% | 83.36% | 88.44% | 193.81% | 108.20% | -67.39% | -4.85% |
AXSM Axsome Therapeutics, Inc. | 39.71% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 296.78% |
Correlation
The correlation between VIST and AXSM is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Jul 26, 2019 | 0.15 |
The correlation between VIST and AXSM shifts across timeframes, from 0.03 (1 year) to 0.15 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
VIST:
$7.95B
AXSM:
$13.06B
VIST:
$6.82
AXSM:
-$3.74
VIST:
2.71
AXSM:
18.13
VIST:
3.06
AXSM:
239.33
VIST:
$2.90B
AXSM:
$708.24M
VIST:
$1.31B
AXSM:
$655.82M
VIST:
$2.12B
AXSM:
-$172.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VIST vs. AXSM — Risk / Return Rank
VIST
AXSM
VIST vs. AXSM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vista Oil & Gas, S.A.B. de C.V. (VIST) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VIST | AXSM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.61 | ||
| Sortino ratioReturn per unit of downside risk | -3.30 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.57 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | 1.04 | 7.62 | -6.59 |
| Martin ratioReturn relative to average drawdown | 2.36 | 22.44 | -20.08 |
Loading charts...
Drawdowns
VIST vs. AXSM - Drawdown Comparison
The maximum VIST drawdown since its inception was -81.19%, smaller than the maximum AXSM drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for VIST and AXSM.
Loading charts...
Drawdown Indicators
| VIST | AXSM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.19% | -86.65% | +5.46% |
Max Drawdown (1Y)Largest decline over 1 year | -36.48% | -18.50% | -17.98% |
Max Drawdown (3Y)Largest decline over 3 years | -43.36% | -36.45% | -6.91% |
Max Drawdown (5Y)Largest decline over 5 years | -43.36% | -72.91% | +29.55% |
Max Drawdown (10Y)Largest decline over 10 years | — | -81.26% | — |
Current DrawdownCurrent decline from peak | -8.97% | 0.00% | -8.97% |
Average DrawdownAverage peak-to-trough decline | -28.22% | -39.47% | +11.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.01% | 6.31% | +9.70% |
Volatility
VIST vs. AXSM - Volatility Comparison
Vista Oil & Gas, S.A.B. de C.V. (VIST) has a higher volatility of 12.74% compared to Axsome Therapeutics, Inc. (AXSM) at 9.24%. This indicates that VIST's price experiences larger fluctuations and is considered to be riskier than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VIST | AXSM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.74% | 9.24% | +3.50% |
Volatility (6M)Calculated over the trailing 6-month period | 32.81% | 33.14% | -0.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.68% | 41.89% | +7.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 52.00% | 70.25% | -18.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.12% | 90.53% | -29.41% |
Dividends
VIST vs. AXSM - Dividend Comparison
Neither VIST nor AXSM has paid dividends to shareholders.
Financials
VIST vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between Vista Oil & Gas, S.A.B. de C.V. and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VIST vs. AXSM - Profitability Comparison
VIST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a gross profit of 472.36M and revenue of 865.01M. Therefore, the gross margin over that period was 54.6%.
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
VIST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported an operating income of 216.12M and revenue of 865.01M, resulting in an operating margin of 25.0%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
VIST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a net income of 107.71M and revenue of 865.01M, resulting in a net margin of 12.5%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
Frequently Asked Questions
VIST and AXSM have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VIST has higher volatility (12.74%) compared to AXSM (9.24%). In terms of maximum drawdown, VIST dropped -81.19% vs AXSM's -86.65%.
AXSM currently has the higher Sharpe Ratio (3.37 vs 0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VIST and AXSM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer